Flagship Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.99M Buy
9,465
+50
+0.5% +$19.9K 2.43% 14
2026
Q2
$3.41M Buy
9,415
+225
+2% +$77K 2.15% 15
2026
Q1
$3.23M Buy
9,190
+533
+6% +$190K 2.38% 14
2025
Q4
$2.83M Buy
+8,657
New +$2.75M 2% 16

Other funds holding AMGN

Flagship Capital Management's AMGN Position: Q3 2026 in Review

Flagship Capital Management increased its Amgen (AMGN) stake by 0.53% in Q3 2026, buying an estimated $19.9K and bringing the position to 9,465 shares worth $3.99M. The position accounts for 2.43% of the portfolio, ranked #14.

Flagship Capital Management first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,038 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Flagship Capital Management held 9,465 shares of Amgen worth $3.99M as of Q3 2026.
  • Flagship Capital Management bought 50 Amgen shares in Q3 2026, an estimated $19.9K.
  • Amgen made up 2.43% of Flagship Capital Management's portfolio in Q3 2026, its #14 holding.
  • Flagship Capital Management first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,038 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Flagship Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.